Source: FierceBiotech Biotech IPOs are faring well this fall. That’s despite tough talk from U.S. politicians on biopharma pricing, as the topic has become a focal point in the presidential elections. In a second IPO of the week, Myovant Sciences ($MYOV) raised a larger-than-expected offering after it priced at the…...

Source: Allergan, which made its name with dermatology products like Botox, recalled more than 42,000 tubes of an acne gel that failed to meet specifications during stability testing. According to the most recent FDA Enforcement Report, Allergan recalled 42,359 tubes of Tazorac in 30-g and 100-g sizes because the gel…...

Source: Business Wire Encore Dermatology, Inc., a leader in developing and commercializing novel, prescription products for improving skin health, today announced the availability of HylatopicPlus® Lotion in a convenient 14 oz. bottle with pump dispenser. HylatopicPlus® Lotion is indicated to manage and relieve the burning, itching and pain experienced with…...

Source: Globe Newswire Journey Medical Corporation, a Fortress Biotech, Inc. (FBIO) company, launched Targadox™ (doxycycline hyclate USP) 50 mg film coated tablets indicated as adjunctive therapy for the treatment of severe acne. Targadox™ is the only 50 mg immediate-release doxycycline hyclate tablet currently available on the market. Targadox™ is available…...

Source: Playing catch-up in the next-gen psoriasis market, Eli Lilly is going all out with its first ad campaign for Taltz, promising “a chance at completely clear skin.” In Lilly’s crosshairs? Novartis’ Cosentyx, which has had a 14-month lead in getting to market first with an IL-17 inhibitor. In the…...

Source: Bloomberg Samsung Biologics Co. is seeking to raise as much as 2.25 trillion won ($2 billion) from a South Korean initial public offering, taking an important step toward its goal of becoming the world’s largest contract manufacturer of biological medicines. The listing of the business, which makes complex drugs…...